Factors | Univariate analysis | Multivariate Analysis | ||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Gender | 0.393 (0.283–0.546) | < 0.001 | 0.538 (0.352–0.821) | 0.004 |
Age (year) | 1.049 (1.033–1.066) | < 0.001 | 1.042 (1.025–1.058) | < 0.001 |
Tumor size (cm) | 1.461 (1.288–1.657) | < 0.001 | 1.274 (1.075–1.510) | 0.005 |
Smoking history | 2.067 (1.558–2.742) | < 0.001 | 1.107 (0.764–1.603) | 0.592 |
8th TNM stage | 1.818 (1.364–2.425) | < 0.001 | 1.196 (0.762–1.878) | 0.437 |
Visceral pleural invasion | 1.281 (0.973–1.687) | 0.077 | 1.180 (0.818–1.702) | 0.377 |
Histology | ||||
Squamous cell carcinoma | Ref | Ref | ||
Adenocarcinoma | 0.629 (0.459–0.864) | 0.004 | 1.061 (0.745–1.513) | 0.742 |
Others | 0,946 (0.581–1.1542) | 0.825 | 1.225 (0.734–2.043) | 0.437 |
Differentiation degree | 1.683 (1.341–2.112) | < 0.001 | 1.349 (1.063–1.711) | 0.014 |
Vascular invasion | 1.899 (1.119–3.222) | 0.017 | 1.398 (0.805–2.429) | 0.235 |
Number of N2 LNs examined | ||||
0–2 | Ref | |||
3–5 | 0.427 (0.244–0.783) | 0.006 | 0.565 (0.302–1.056) | 0.073 |
6–8 | 0.629 (0.368–1.073) | 0.089 | 0.745 (0.429–1.294) | 0.296 |
9–11 | 0.516 (0.292–0.913) | 0.023 | 0.663 (0.367–1.198) | 0.174 |
12–14 | 0.648 (0.372–1.129) | 0.126 | 0.887 (0.497–1.583) | 0.686 |
> 14 | 0.563 (0.342–0.929) | 0.024 | 0.654 (0.388–1.102) | 0.111 |
Adjuvant chemotherapy | 0.925 (0.625–1.369) | 0.695 | ||
Thoracotomy or VATS | 0.864 (0.655–1.141) | 0.304 | ||
Number of N1 LNs examined | ||||
0–2 | Ref | Ref | ||
3–5 | 0.702 (0.451–1.091) | 0.116 | 0.631 (0.403–0.987) | 0.044 |
6–8 | 0.533 (0.336–0.844) | 0.007 | 0.489 (0.307–0.779) | 0.003 |
9–11 | 0.630 (0.398–0.997) | 0.049 | 0.599 (0.375–0.957) | 0.032 |
> 11 | 0.527 (0.329–1.845) | 0.008 | 0.434 (0.269–0.701) | 0.001 |